Association of complement receptor 1 (CR1, CD35, C3b/C4b receptor) density polymorphism with glomerulonephritis in Indian subjects

Molecular Immunology

Volumn 40, Issue 18, 2004, Pages 1325-1332

  Katyal, Monika ^a   Tiwari, S C ^a   Kumar, Ashok ^a   Dinda, A K ^a   Arora, Vaishali ^a   Kumar, Rajiv ^b   Das, Nibhriti ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

CR1 catabolism; Density polymorphism; Disease susceptibility; Erythrocyte complement receptor 1 (E CR1); Glomerulonephritis; HH genotype; Indian subjects

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; INDIAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEPTOR DENSITY;

ADULT; AUTOIMMUNE DISEASES; ERYTHROCYTE MEMBRANE; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLOMERULONEPHRITIS; HUMANS; IMMUNE COMPLEX DISEASES; INDIA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, COMPLEMENT 3B;

EID: 1842557723     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2003.12.003     Document Type: Article

References (25)

1. Anand V., Dinda A.K., Raju K.R., Arora M., Tiwari S.C., Srivastava L.M. Differential CR1 expression in adult and pediatric age groups of patients with minimal change nephrotic syndrome. Nephron. 77:1997;482-483.
2. Arora M., Arora R., Tiwari S.C., Das N., Srivastava L.M. Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis. Lupus. 9:2000;127-131.
3. Arora M., Jain D., Dinda A.K., Das S.N., Anand V., Tiwari S.C., Srivastava L.M. Reduced CR1 expression on erythrocytes of idiopathic focal-segmental glomerulosclerosis patients. Nephron. 79:1998;365-366.
4. Cohen J.H.M., Lutz H.U., Pennaforte J.L., Bouchard A. Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 87:1992;422-428.
5. Cornillet P., Philbert F., Kazatchkine M.D., Cohen J.H.M. Genomic determination of CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and HindIII restriction enzyme digestion. J. Immunol. Methods. 136:1991;193-197.
6. Cosio F.G., Xiao-Ping S., Birmingham D.J., Shen X.P., Van Aman M., Hebert L.A. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J. Immunol. 145:1990;4198-4206.
7. Csipo I., Kiss E., Soltesz P., Antal-Szalmas P., Cohen J.H.M. Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type 1 (CR1) of patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 118:1999;458-464.
8. Dykman T.R., Hatch J.A., Aqua M.S., Atkinson J.P. Polymorphism of the C3b/C4b receptor (CR1): characterization of a fourth allele. J. Immunol. 134:1985;1787-1789.
9. Hebert L.A. The clearance of immune complexes from the circulation of man and other primates. Am. J. Kidney Dis. 17:1991;352-361.
10. Klickstein L.B., Bartow T.J., Miletic V., Rabson L.D., Smith J.A., Fearon D.T. Identification of distinct C3b and C4b recognition sites in the human C3b/C3b receptor (CR1, CD35 by deletion mutagenesis. J. Exp. Med. 168:1988;1699-1717.
11. Kumar A., Malaviya A.N., Sinha S., Khandekar P.S., Banerjee K., Srivastava L.M. C3b receptor (CR1) genomic polymorphism in rheumatoid arthritis. Immunol. Res. 13:1994a;61-71.
12. Kumar A., Malaviya A.N., Srivastava L.M. Lowered expression of C3b receptor (CR1) on erythrocytes of rheumatoid arthritis patients. Immunobiology. 191:1994b;9-20.
13. Lublin D.M., Griffith R.C., Atkinson J.P. Influence of glycosylation on allelic and cell-specific Mr. variation, receptor processing and ligand binding of the human complement C3b/C4b receptor. J. Biol. Chem. 261:1986;5736-5744.
14. Madi N., Steiger G., Estreicher J., Schifferli J.A. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1). Clin. Exp. Immunol. 85:1991;9-15.
15. Marquart H.V., Svendsen A., Rasmussen J.M., Nielsen C.H., Junker P., Svehag S.E., Leslie R.G.Q. Complement receptor expression and activation of the complement cascade on B-lymphocytes from patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 101:1995;60-65.
16. Mitchell J.A., Sim R.B., Sim E. CR1 polymorphism in hydralazine induced SLE: DNA restriction fragment length polymorphism. Clin. Exp. Immunol. 78:1989;354-358.
17. Moldenhauer F., David J., Fielder A.H.L., Lachmann P.J., Walport M.J. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus. Arthritis Rheum. 30:1987;961-966.
18. Panchamoorthy G., Tiwari S.C., Srivastava L.M. Inherited structural and quantitative polymorphism of C3b receptor (CR1) in normals and patients with glomerular diseases. Asian Pacific J. Allergy Immunol. 11:1993;123-129.
19. Pascual M., Danielsson C., Steiger G., Schifferli J.A. Proteolytic cleavage of CR1 on human erythrocytes in vivo: evidence for enhanced cleavage in AIDS. Eur. J. Immunol. 24(3):1994a;702-708.
20. Pascual M., Steiger G., Sadallah S., Paccaud J.P., Carpentier J.L., James R., Schifferli J.A. Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes. J. Exp. Med. 179:1994b;889-899.
21. Walport M.J., Ross G.D., Mackworth C., Watson J.V. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin. Exp. Immunol. 59:1985;547-554.
22. Wilson J.G., Murphy E.E., Wong W.W., Klickstein L.B., Weis J.H., Fearon D.T. Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J. Exp. Med. 164:1986;50-59.
23. Wilson J.G., Wong W.W., Peter B.S., Schur P.H., Fearon D.T. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. New Engl. J. Med. 16:1982;981-984.
24. Wilson J.G., Ratnoff W.D., Schur P.H., Fearon D.T. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B-lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum. 29:1986;739-747.
25. Wilson J.G., Wong W.W., Murphy E.E., Schur P.H., Fearon D.T. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene. J. Immunol. 138:1987;2706-2708.